Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
August 06 2019 - 04:05PM
Business Wire
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine
company, announced today that CEO Sandy Macrae will present at the
2019 Wedbush PacGrow Healthcare Conference in New York City.
The presentation is scheduled for Wednesday, August 14 at 1:20 p.m.
Eastern Time.
The Wedbush presentation will be webcast live and may be
accessed via a link on the Sangamo Therapeutics website in the
Investors and Media section under Events and Presentations. The
presentation will also be available on the Sangamo website after
the event.
Earlier in the week, Dr. Macrae will participate in the BTIG
Biotechnology Conference 2019 in a panel discussion, “Exploring
the Novel Approaches to Treating Sickle Cell Disease”. This event
is scheduled for Monday, August 12 at 1:00 p.m. Eastern Time. No
webcast is available for the BTIG event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking
science into genomic medicines with the potential to transform
patients’ lives using gene therapy, ex vivo gene-edited cell
therapy, and in vivo genome editing and gene regulation. For more
information about Sangamo, visit www.sangamo.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190806005815/en/
Investor Relations – Global McDavid
Stilwell 510-970-6000, x219 mstilwell@sangamo.com
Media Inquiries – Global Aron
Feingold 510-970-6000, x421 afeingold@sangamo.com
Investor Relations and Media Inquiries –
European Union & United Kingdom Caroline Courme 33 4 97
21 27 27 ccourme@sangamo.com
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Sangamo Therapeutics (NASDAQ:SGMO)
Historical Stock Chart
From Mar 2023 to Mar 2024